Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 11
Submit an article Journal homepage
319
Views
0
CrossRef citations to date
0
Altmetric
Diabetes

The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010–2018

Piaopiao Lia Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA
,
Rahul Patela Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA
,
Jingchuan Guoa Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA;b Center for Drug Evaluation and Safety, University of Florida College of Pharmacy, Gainesville, FL, USA
,
Scott M. Vouria Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA
,
Lizheng Shic Department of Health Policy and Management, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA
,
Vivian Fonsecad Department of Medicine and Pharmacology, School of Medicine, Tulane University, New Orleans, LA, USA
&
Hui Shaoa Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USACorrespondence[email protected]
 show all
Pages 1875-1880 | Received 11 Mar 2021, Accepted 15 Aug 2021, Published online: 31 Aug 2021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010–2018
Source: Taylor & Francis
The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010–2018
Source: Taylor & Francis
The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010-2018
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.